Drug manufacturer Purdue Pharma is on board to build a new plant in Durham which will become the company’s second North Carolina facility.

Connecticut-based Purdue, which makes pain products such as OxyContin and Butrans, will invest $59 million in the new Durham plant over the next three years, under an agreement with North Carolina officials. The project, announced Wednesday by Gov. Pat McCrory and North Carolina Commerce Secretary Sharon Decker, is projected to create 100 new jobs.

Privately-held Purdue already operates a manufacturing plant in Wilson, a site that opened in 2000 and created about 180 engineering, scientific and technical jobs. That plant pioneered product tracking and anti-counterfeit packaging for authentication and traceability of products from Purdue warehouses to pharmacy shelves.

Annual salaries at the Durham plant will average $70,199, plus benefits, topping the $66,602 average annual wage in Durham County.

“This decision underscores Purdue’s commitment to the Raleigh/Durham region, and solidifies the company’s footprint in North Carolina through the establishment of a manufacturing and technology hub,” Purdue President and CEO John Stewart said in a statement. “This decision also reflects Purdue’s ongoing commitment to invest in high-tech jobs within the state.”

Purdue is receiving some state incentives for the project. The company was awarded a One North Carolina Fund grant of up to $300,000. Like other One NC Fund grant recipients, Purdue receives no money up front and must meet job creation and investment performance targets in order to get the money. The grant also requires local matches.